Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Efficient Recombinant Annexin V Purification for Biophysical
2026-05-13
This study introduces a rapid, high-purity protocol for recombinant annexin V purification, optimizing protein integrity for structural and electrophysiological research. The approach minimizes contaminant carryover and facilitates advanced functional analyses, with broader relevance for protein expression workflows involving β-lactam antibiotic selection.
-
N1-Methyl-Pseudouridine-5'-Triphosphate: Transforming RNA Th
2026-05-13
Explore how N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) underpins next-generation RNA therapeutics and immunotherapies by enhancing RNA stability and enabling precision modulation of the tumor microenvironment. Discover unique mechanistic insights and practical assay strategies rooted in recent landmark research.
-
SR-202: Unlocking PPARγ Antagonism for Translational Metabol
2026-05-12
This article provides a mechanistic and strategic analysis of SR-202, a selective PPARγ antagonist, emphasizing its role in insulin resistance, obesity, and immunometabolic disease research. Integrating recent evidence on macrophage polarization and immune-metabolic crosstalk, we outline how SR-202 enables next-generation translational studies and protocol optimization.
-
D-N-Acetylgalactosamine: Technical Use in Brain Glycoprotein
2026-05-12
D-N-Acetylgalactosamine is a high-purity, water-soluble biochemical essential for investigating glycoprotein structure and glycosylation in brain research. It should not be used in protocols requiring ethanol solubility or where long-term storage of working solutions is necessary. For reproducible results, adherence to product-specific handling and workflow recommendations is critical.
-
PD0325901: MEK Inhibitor Workflows for Cancer Research Succe
2026-05-11
PD0325901 is a benchmark MEK inhibitor empowering researchers to dissect RAS/RAF/MEK/ERK signaling with precision, enabling robust cell cycle arrest and apoptosis in cancer models. This article delivers stepwise experimental workflows, data-backed troubleshooting, and translational insights—bridging advanced pathway inhibition with reproducible tumor suppression in vitro and in vivo.
-
Cefodizime: Antibacterial Activity, Pharmacokinetics, and Cl
2026-05-11
This review by Barradell and Brogden comprehensively evaluates cefodizime—a third-generation cephalosporin antibiotic—for its broad-spectrum antibacterial activity, pharmacokinetics, and therapeutic efficacy. The study highlights cefodizime’s robust in vitro and clinical performance, especially for respiratory and urinary tract infections, and discusses its potential immunomodulatory effects, making it a valuable reference for antimicrobial research and clinical translation.
-
Carboxylesterase Interference in Amplex Red H2O2 Assays: Imp
2026-05-10
This study reveals that carboxylesterases can artificially convert Amplex Red to resorufin in mitochondrial H2O2 release assays, independent of hydrogen peroxide or horseradish peroxidase. The finding necessitates critical reevaluation of past ROS quantification results and provides practical means to mitigate assay artifacts.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Streamlining mRNA Delivery Ana
2026-05-09
ARCA Cy5 EGFP mRNA (5-moUTP) empowers researchers to visualize, quantify, and troubleshoot mRNA delivery in mammalian cells with unprecedented clarity. Its dual fluorescent labeling and immune-silent 5-methoxyuridine modification offer robust, reproducible workflows for mRNA localization and translation efficiency assays.
-
Halazone: Mechanistic Insights and Next-Generation Uses in R
2026-05-08
Explore the multifaceted role of Halazone as an antimicrobial sulfonamide derivative, delving into its dual mechanism in water disinfection and sodium channel modulation. This article provides a unique analysis of protocol optimization and translational potential, distinguishing itself from prior reviews.
-
Cyanine 5-dCTP: High-Fidelity Fluorescent Nucleotide for DNA
2026-05-08
Cyanine 5-dCTP (Cy5-dCTP) is a fluorescent nucleotide triphosphate enabling robust, site-specific DNA labeling in enzymatic synthesis workflows. Its high purity and strong red fluorescence support applications in PCR, probe synthesis, and fluorescence microscopy, delivering high signal fidelity under controlled conditions.
-
Applied Cancer Research with Pazopanib (GW-786034): Protocol
2026-05-07
Pazopanib (GW-786034) empowers translational cancer research by targeting multiple angiogenic pathways, offering precision in both in vitro and in vivo models. This guide delivers actionable workflows, troubleshooting strategies, and real-world data for maximizing anti-tumor efficacy with APExBIO's trusted reagent.
-
Pazopanib (GW-786034): Precision Targeting for ATRX-Deficien
2026-05-07
Explore how Pazopanib (GW-786034) leverages multi-kinase inhibition for advanced cancer research, with a unique focus on ATRX-deficient models and translational assay guidance. Uncover practical protocol nuances and the latest evidence for optimized experimental design.
-
ATRX Deficiency Sensitizes High-Grade Glioma to RTK Inhibito
2026-05-06
Pladevall-Morera et al. identified that ATRX-deficient high-grade glioma cells display heightened sensitivity to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. This finding suggests the ATRX mutation status could guide more effective, precision-targeted therapeutic strategies and influence clinical trial design for gliomas.
-
2,5-di-tert-butylbenzene-1,4-diol (BHQ) in Calcium Signaling
2026-05-06
2,5-di-tert-butylbenzene-1,4-diol (BHQ) enables precise, reproducible inhibition of SERCA, unlocking new avenues in calcium signaling research and stem cell mobilization. This article provides hands-on workflow enhancements, troubleshooting strategies, and translation of the latest mechanistic breakthroughs for advanced experimental design.
-
Cell Counting Kit-8 Plus: Sensitive Tetrazolium Salt Assay W
2026-05-05
Cell Counting Kit-8 (CCK-8) Plus empowers researchers to quantify cell proliferation and cytotoxicity with superior sensitivity and speed. This guide details optimized workflows, advanced applications, and troubleshooting strategies for robust WST-8-based assays, drawing on the latest colorectal cancer research and validated protocol enhancements.